Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Eferl

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
American Journal of Cancer Research|September 19, 2014
STAT3β controls inflammatory responses and early tumor onset in skin and colon experimental cancer modelsFrancesca Marino, Valeria Orecchia, Gabriella Regis, et al.
The Journal of Pathology|November 22, 2013
Meprin β, a novel mediator of vascular remodelling underlying pulmonary hypertensionValentina Biasin, Leigh M Marsh, Bakytbek Egemnazarov, et al.
Plos One|October 11, 2012
NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis developmentPatricia Sancho, Jèssica Mainez, Eva Crosas-Molist, et al.
Cancer Medicine|March 10, 2025
Radiation-Enhanced AF1q Moves Center Stage as a Key Driver to Favorable Tumor Stage in Rectal Cancer PatientsElisabeth S Gruber, Georg Oberhuber, Elisabeth Gurnhofer, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 29, 2016
Epidermal growth factor signaling protects from cholestatic liver injury and fibrosisJasmin Svinka, Sandra Pflügler, Markus Mair, et al.
International Journal of Molecular Sciences|May 14, 2022
AOM/DSS Induced Colitis-Associated Colorectal Cancer in 14-Month-Old Female Balb/C and C57/Bl6 Mice-A Pilot StudyMartin Schepelmann, Nadja Kupper, Valeriya Gushchina, et al.
Gastroenterology|December 8, 2009
Stat3 is a negative regulator of intestinal tumor progression in Apc(Min) miceMonica Musteanu, Leander Blaas, Markus Mair, et al.
Nature|June 13, 2008
Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxiaAline Bozec, Latifa Bakiri, Astrid Hoebertz, et al.
Plos One|February 4, 2014
Inducible, dose-adjustable and time-restricted reconstitution of STAT1 deficiency in vivoNicole R Leitner, Caroline Lassnig, Rita Rom, et al.
Cancers|August 25, 2019
A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease ConditionsHerwig P Moll, Julian Mohrherr, Leander Blaas, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
American Journal of Cancer Research|September 19, 2014
STAT3β controls inflammatory responses and early tumor onset in skin and colon experimental cancer modelsFrancesca Marino, Valeria Orecchia, Gabriella Regis, et al.
The Journal of Pathology|November 22, 2013
Meprin β, a novel mediator of vascular remodelling underlying pulmonary hypertensionValentina Biasin, Leigh M Marsh, Bakytbek Egemnazarov, et al.
Plos One|October 11, 2012
NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis developmentPatricia Sancho, Jèssica Mainez, Eva Crosas-Molist, et al.
Cancer Medicine|March 10, 2025
Radiation-Enhanced AF1q Moves Center Stage as a Key Driver to Favorable Tumor Stage in Rectal Cancer PatientsElisabeth S Gruber, Georg Oberhuber, Elisabeth Gurnhofer, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 29, 2016
Epidermal growth factor signaling protects from cholestatic liver injury and fibrosisJasmin Svinka, Sandra Pflügler, Markus Mair, et al.
International Journal of Molecular Sciences|May 14, 2022
AOM/DSS Induced Colitis-Associated Colorectal Cancer in 14-Month-Old Female Balb/C and C57/Bl6 Mice-A Pilot StudyMartin Schepelmann, Nadja Kupper, Valeriya Gushchina, et al.
Gastroenterology|December 8, 2009
Stat3 is a negative regulator of intestinal tumor progression in Apc(Min) miceMonica Musteanu, Leander Blaas, Markus Mair, et al.
Nature|June 13, 2008
Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxiaAline Bozec, Latifa Bakiri, Astrid Hoebertz, et al.
Plos One|February 4, 2014
Inducible, dose-adjustable and time-restricted reconstitution of STAT1 deficiency in vivoNicole R Leitner, Caroline Lassnig, Rita Rom, et al.
Cancers|August 25, 2019
A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease ConditionsHerwig P Moll, Julian Mohrherr, Leander Blaas, et al.
Pageof 8